J0717 Insurance Policy Changes

HCPCS J0717 is officially defined as "Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)." HCPCS J0717 is referenced in 2 tracked payer policy changes from BCBS Tennessee and Texas Medicaid. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J0717 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.